ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program

Molecular and Cellular Biology

Volumn 27, Issue 17, 2007, Pages 6163-6176

  Pelosi, Michele ^a   Marampon, Francesco ^b   Zani, Bianca M ^a,b   Prudente, Sabrina ^c   Perlas, Emerald ^a   Caputo, Viviana ^c   Cianetti, Luciano ^d   Berno, Valeria ^a   Narumiya, Shuh ^e   Kang, Shin W ^f   Musarò, Antonio ^g   Rosenthal, Nadia ^a  

^a EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e KYOTO UNIVERSITY   (Japan)

^f IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 2; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOD PROTEIN; PROTEIN SERINE THREONINE KINASE; RHO KINASE; RHO KINASE 2; S6 KINASE; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SIZE; CELL TRANSFORMATION; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; GENE EXPRESSION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; MOUSE; MUSCLE DEVELOPMENT; MUSCLE HYPERTROPHY; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ALTERNATIVE SPLICING; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DESMIN; ENZYME ACTIVATION; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; ISOENZYMES; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOD PROTEIN; MYOGENIC REGULATORY FACTORS; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

EUKARYOTA;

EID: 34548275925     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.01735-06     Document Type: Article

References (51)

1. Amano, M., K. Chihara, N. Nakamura, T. Kaneko, Y. Matsuura, and K. Kaibuchi. 1999. The COOH terminus of Rho-kinase negatively regulates rho-kinase activity. J. Biol. Chem. 274:32418-32424.
2. Bennett, A. M., and N. K. Tonks. 1997. Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278:1288-1291.
3. Blom, N., S. Gammeltoft, and S. Brunak. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1351-1362.
4. Buckingham, M., L. Bajard, T. Chang, P. Daubas, J. Hadchouel, S. Meilhac, D. Montarras, D. Rocancourt, and F. Relaix. 2003. The formation of skeletal muscle: from somite to limb. J. Anat. 202:59-68.
5. Burge, C., and S. Karlin. 1997. Prediction of complete gene structures in human genomic DNA. J. Mol. Biol. 268:78-94.
6. Carnac, G., M. Primig, M. Kitzmann, P. Chafey, D. Tuil, N. Lamb, and A. Fernandez. 1998. RhoA GTPase and serum response factor control selectively the expression of MyoD without affecting Myf5 in mouse myoblasts. Mol. Biol. Cell 9:1891-1902.
7. Castellani, L., E. Salvati, S. Alema, and G. Falcone. 2006. Fine regulation of RhoA and Rock is required for skeletal muscle differentiation. J. Biol. Chem. 281:15249-15257.
8. Charrasse, S., F. Comunale, Y. Grumbach, F. Poulat, A. Blangy, and C. Gauthier-Rouviere. 2006. RhoA GTPase regulates M-cadherin activity and myoblast fusion. Mol. Biol. Cell 17:749-759.
9. Coolican, S. A., D. S. Samuel, D. Z. Ewton, F. J. McWade, and J. R. Florini. 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. J. Biol. Chem. 272:6653- 6662.
10. Dalby, K. N., N. Morrice, F. B. Caudwell, J. Avruch, and P. Cohen. 1998. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J. Biol. Chem. 273:1496-1505.
11. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
12. Dhawan, J., and D. M. Helfman. 2004. Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation. J. Cell Sci. 117:3735-3748.
13. Dufresne, S. D., C. Bjorbaek, K. El-Haschimi, Y. Zhao, W. G. Aschenbach, D. E. Moller, and L. J. Goodyear. 2001. Altered extracellular signal-regulated kinase signaling and glycogen metabolism in skeletal muscle from p90 ribosomal S6 kinase 2 knockout mice. Mol. Cell. Biol. 21:81-87.
14. Etienne-Manneville, S., and A. Hall. 2002. Rho GTPases in cell biology. Nature 420:629-635.
15. Gredinger, E., A. N. Gerber, Y. Tamir, S. J. Tapscott, and E. Bengal. 1998. Mitogen-activated protein kinase pathway is involved in the differentiation of muscle cells. J. Biol. Chem. 273:10436-10444.
16. Ishizaki, T., M. Uehata, I. Tamechika, J. Keel, K. Nonomura, M. Maekawa, and S. Narumiya. 2000. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol. Pharmacol. 57:976-983.
17. Kelly, A. M., and S. I. Zacks. 1968. Neuromuscular development in intercostal muscle of the fetal and newborn rat. J. Neuropathol. Exp. Neurol. 27:109.
18. Kuwahara, K., T. Barrientos, G. C. Pipes, S. Li, and E. N. Olson. 2005. Muscle-specific signaling mechanism that links actin dynamics to serum response factor. Mol. Cell. Biol. 25:3173-3181.
19. Leung, T., X.-Q. Chen, E. Manser, and L. Lim. 1996. The p160 RhoA-binding kinase ROKα is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol. Cell. Biol. 16:5313-5327.
20. Lluis, F., E. Perdiguero, A. R. Nebreda, and P. Munoz-Canoves. 2006. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16:36-44.
21. Matsui, T., M. Amano, T. Yamamoto, K. Chihara, M. Nakafuku, M. Ito, T. Nakano, K. Okawa, A. Iwamatsu, and K. Kaibuchi. 1996. Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho. EMBO J. 15:2208-2216.
22. McKinsey, T. A., C. L. Zhang, and E. N. Olson. 2002. Signaling chromatin to make muscle. Curr. Opin. Cell Biol. 14:763-772.
23. McManus, M. T., B. B. Haines, C. P. Dillon, C. E. Whitehurst, L. van Parijs, J. Chen, and P. A. Sharp. 2002. Small interfering RNA-mediated gene silencing in T lymphocytes. J. Immunol. 169:5754-5760.
24. McMullan, R., S. Lax, V. H. Robertson, D. J. Radford, S. Broad, F. M. Watt, A. Rowles, D. R. Croft, M. F. Olson, and N. A. Hotchin. 2003. Keratinocyte differentiation is regulated by the Rho and ROCK signaling pathway. Curr. Biol. 13:2185-2189.
25. Megeney, L. A., B. Kablar, K. Garrett, J. E. Anderson, and M. A. Rudnicki. 1996. MyoD is required for myogenic stem cell function in adult skeletal muscle. Genes Dev. 10:1173-1183.
26. Musaro, A., K. J. McCullagh, F. J. Naya, E. N. Olson, and N. Rosenthal. 1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400:581-585.
27. Musaro, A., and N. Rosenthal. 1999. Maturation of the myogenic program is induced by postmitotic expression of insulin-like growth factor I. Mol. Cell. Biol. 19:3115-3124.
28. Nakagawa, O., K. Fujisawa, T. Ishizaki, Y. Saito, K. Nakao, and S. Narumiya. 1996. ROCK-I and ROCK-II, two isoforms of Rho-associated coiled-coil forming protein serine/threonine kinase in mice. FEBS Lett. 392:189-193.
29. Nishiyama, T., I. Kii, and A. Kudo. 2004. Inactivation of Rho/ROCK signaling is crucial for the nuclear accumulation of FKHR and myoblast fusion. J. Biol. Chem. 279:47311-47319.
30. Ordahl, C. P., and N. M. Le Douarin. 1992. Two myogenic lineages within the developing somite. Development 114:339-353.
31. Parker, M. H., P. Seale, and M. A. Rudnicki. 2003. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat. Rev. Genet. 4:497-507.
32. Riento, K., and A. J. Ridley. 2003. Rocks: multifunctional kinases in cell behaviour. Nat. Rev. Mol. Cell. Biol. 4:446-456.
33. Roux, P. P., S. A. Richards, and J. Blenis. 2003. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity. Mol. Cell. Biol. 23:4796-4804.
34. Rudnicki, M. A., T. Braun, S. Hinuma, and R. Jaenisch. 1992. Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development. Cell 71:383-390.
35. Sarbassov, D. D., L. G. Jones, and C. A. Peterson. 1997. Extracellular signal-regulated kinase-1 and -2 respond differently to mitogenic and differentiative signaling pathways in myoblasts. Mol. Endocrinol. 11:2038-2047.
36. Shen, X., J. M. Collier, M. Hlaing, L. Zhang, E. H. Delshad, J. Bristow, and H. S. Bernstein. 2003. Genome-wide examination of myoblast cell cycle withdrawal during differentiation. Dev. Dyn. 226:128-138.
37. Shimizu, Y., D. Thumkeo, J. Keel, T. Ishizaki, H. Oshima, M. Oshima, Y. Noda, F. Matsumura, M. M. Taketo, and S. Narumiya. 2005. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J. Cell Biol. 168:941-953.
38. Somlyo, A. P., and A. V. Somlyo. 2003. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 83:1325-1358.
39. Sordella, R., W. Jiang, G. C. Chen, M. Curto, and J. Settleman. 2003. Modulation of Rho GTPase signaling regulates a switch between adipogenesis and myogenesis. Cell 113:147-158.
40. Takano, H., I. Komuro, T. Oka, I. Shiojima, Y. Hiroi, T. Mizuno, and Y. Yazaki. 1998. The Rho family G proteins play a critical role in muscle differentiation. Mol. Cell. Biol. 18:1580-1589.
41. Thumkeo, D., J. Keel, T. Ishizaki, M. Hirose, K. Nonomura, H. Oshima, M. Oshima, M. M. Taketo, and S. Narumiya. 2003. Targeted disruption of the mouse Rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol. Cell. Biol. 23:5043-5055.
42. Thumkeo, D., Y. Shimizu, S. Sakamoto, S. Yamada, and S. Narumiya. 2005. ROCK-I and ROCK-II cooperatively regulate closure of eyelid and ventral body wall in mouse embryo. Genes Cells 10:825-834.
43. Tureckova, J., E. M. Wilson, J. L. Cappalonga, and P. Rotwein. 2001. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin. J. Biol. Chem. 276:39264-39270.
44. Walsh, K., and H. Perlman. 1997. Cell cycle exit upon myogenic differentiation. Curr. Opin. Genet. Dev. 7:597-602.
45. Wang, J., and K. Walsh. 1996. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359-361.
46. Wang, X., W. Li, M. Williams, N. Terada, D. R. Alessi, and C. G. Proud. 2001. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 20:4370-4379.
47. Wei, L., W. Roberts, L. Wang, M. Yamada, S. Zhang, Z. Zhao, S. A. Rivkees, R. J. Schwartz, and K. Imanaka-Yoshida. 2001. Rho kinases play an obligatory role in vertebrate embryonic organogenesis. Development 128:2953-2962.
48. Wei, L., W. Zhou, J. D. Croissant, F. E. Johansen, R. Prywes, A. Balasubramanyam, and R. J. Schwartz. 1998. RhoA signaling via serum response factor plays an obligatory role in myogenic differentiation. J. Biol. Chem. 273:30287-30294.
49. Weintraub, H. 1993. The MyoD family and myogenesis: redundancy, networks, and thresholds. Cell 75:1241-1244.
50. Zetser, A., E. Gredinger, and E. Bengal. 1999. p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274:5193-5200.
51. Zhao, Y., C. Bjorbaek, and D. E. Moller. 1996. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases. J. Biol. Chem. 271:29773-29779.